Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3010% above fair value
$259.09−0.60 (-0.23%)
Close on Nov 19, 2026Market cap $28.50BP/E 25.8Yield –
Quest Diagnostics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Quest Diagnostics's free cash flow for the twelve months ending Sep 30, 2026 was $1.38B, down 1.3% year over year. For fiscal 2025 it was $1.36B, up 49.5% from the year before. Over ten years it grew 9.3% a year on average. The highest annual figure on record is $1.83B in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.36B | +49.5% |
| FY2024 | Dec 31, 2024 | $909.00M | +5.2% |
| FY2023 | Dec 31, 2023 | $864.00M | -34.2% |
| FY2022 | Dec 31, 2022 | $1.31B | -28.2% |
| FY2021 | Dec 31, 2021 | $1.83B | +15.3% |
| FY2020 | Dec 31, 2020 | $1.59B | +88.3% |
| FY2019 | Dec 31, 2019 | $843.00M | +3.2% |
| FY2018 | Dec 31, 2018 | $817.00M | -11.5% |
| FY2017 | Dec 31, 2017 | $923.00M | +12.2% |
| FY2016 | Dec 31, 2016 | $823.00M | +47.5% |
| FY2015 | Dec 31, 2015 | $558.00M | -12.3% |
| FY2014 | Dec 31, 2014 | $636.00M | +51.1% |
| FY2013 | Dec 31, 2013 | $421.00M | -58.1% |
| FY2012 | Dec 31, 2012 | $1.01B | +36.9% |
| FY2011 | Dec 31, 2011 | $734.00M | -19.6% |
| FY2010 | Dec 31, 2010 | $912.65M | +9.9% |
| FY2009 | Dec 31, 2009 | $830.49M | -2.3% |
| FY2008 | Dec 31, 2008 | $850.37M | +20.1% |
| FY2007 | Dec 31, 2007 | $707.82M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $445.00M | +6.2% |
| Q2 FY2026 | Jun 30, 2026 | $459.00M | +5.3% |
| Q1 FY2026 | Mar 31, 2026 | $164.00M | -16.8% |
| Q4 FY2025 | Dec 31, 2025 | $307.00M | -10.0% |
| Q3 FY2025 | Sep 30, 2025 | $419.00M | +67.6% |
| Q2 FY2025 | Jun 30, 2025 | $436.00M | +62.7% |
| Q1 FY2025 | Mar 31, 2025 | $197.00M | +294.0% |
| Q4 FY2024 | Dec 31, 2024 | $341.00M | -25.1% |
| Q3 FY2024 | Sep 30, 2024 | $250.00M | +145.1% |
| Q2 FY2024 | Jun 30, 2024 | $268.00M | -21.2% |
| Q1 FY2024 | Mar 31, 2024 | $50.00M | – |
| Q4 FY2023 | Dec 31, 2023 | $455.00M | +143.3% |
| Q3 FY2023 | Sep 30, 2023 | $102.00M | -73.4% |
| Q2 FY2023 | Jun 30, 2023 | $340.00M | +4.3% |
| Q1 FY2023 | Mar 31, 2023 | -$33.00M | -107.9% |
| Q4 FY2022 | Dec 31, 2022 | $187.00M | -44.5% |
| Q3 FY2022 | Sep 30, 2022 | $384.00M | -18.6% |
| Q2 FY2022 | Jun 30, 2022 | $326.00M | -13.3% |
| Q1 FY2022 | Mar 31, 2022 | $417.00M | -35.3% |
| Q4 FY2021 | Dec 31, 2021 | $337.00M | -11.1% |
| Q3 FY2021 | Sep 30, 2021 | $472.00M | -38.8% |
| Q2 FY2021 | Jun 30, 2021 | $376.00M | +37.7% |
| Q1 FY2021 | Mar 31, 2021 | $645.00M | +293.3% |
| Q4 FY2020 | Dec 31, 2020 | $379.00M | +115.3% |
| Q3 FY2020 | Sep 30, 2020 | $771.00M | +279.8% |
| Q2 FY2020 | Jun 30, 2020 | $273.00M | +15.7% |
| Q1 FY2020 | Mar 31, 2020 | $164.00M | -28.1% |
| Q4 FY2019 | Dec 31, 2019 | $176.00M | +22.2% |
| Q3 FY2019 | Sep 30, 2019 | $203.00M | -36.8% |
| Q2 FY2019 | Jun 30, 2019 | $236.00M | -3.7% |
| Q1 FY2019 | Mar 31, 2019 | $228.00M | +113.1% |
| Q4 FY2018 | Dec 31, 2018 | $144.00M | -40.2% |
| Q3 FY2018 | Sep 30, 2018 | $321.00M | +7.4% |
| Q2 FY2018 | Jun 30, 2018 | $245.00M | +7.0% |
| Q1 FY2018 | Mar 31, 2018 | $107.00M | -30.5% |
| Q4 FY2017 | Dec 31, 2017 | $241.00M | +8.1% |
| Q3 FY2017 | Sep 30, 2017 | $299.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $229.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $154.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $223.00M | – |
See a number that looks wrong?